- Home
- IMNM vs MCBS Comparison
IMNM vs MCBS Comparison
Compare IMNM & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- MCBS
- Stock Information
- Founded
- IMNM 2006
- MCBS 2006
- Country
- IMNM United States
- MCBS United States
- Employees
- IMNM N/A
- MCBS N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- MCBS Major Banks
- Sector
- IMNM Health Care
- MCBS Finance
- Exchange
- IMNM Nasdaq
- MCBS Nasdaq
- Market Cap
- IMNM 747.7M
- MCBS 862.8M
- IPO Year
- IMNM 2020
- MCBS 2019
- Fundamental
- Price
- IMNM $9.91
- MCBS $33.91
- Analyst Decision
- IMNM Strong Buy
- MCBS Hold
- Analyst Count
- IMNM 5
- MCBS 1
- Target Price
- IMNM $28.60
- MCBS $34.00
- AVG Volume (30 Days)
- IMNM 695.8K
- MCBS 41.6K
- Earning Date
- IMNM 11-13-2024
- MCBS 10-18-2024
- Dividend Yield
- IMNM N/A
- MCBS 2.71%
- EPS Growth
- IMNM N/A
- MCBS 17.79
- EPS
- IMNM N/A
- MCBS 2.33
- Revenue
- IMNM $10,129,000.00
- MCBS $135,566,000.00
- Revenue This Year
- IMNM N/A
- MCBS N/A
- Revenue Next Year
- IMNM N/A
- MCBS $3.39
- P/E Ratio
- IMNM N/A
- MCBS $14.55
- Revenue Growth
- IMNM N/A
- MCBS 11.66
- 52 Week Low
- IMNM $6.93
- MCBS $19.85
- 52 Week High
- IMNM $30.96
- MCBS $35.79
- Technical
- Relative Strength Index (RSI)
- IMNM 30.69
- MCBS 60.22
- Support Level
- IMNM $12.46
- MCBS $33.04
- Resistance Level
- IMNM $13.52
- MCBS $35.59
- Average True Range (ATR)
- IMNM 0.85
- MCBS 1.05
- MACD
- IMNM -0.15
- MCBS 0.29
- Stochastic Oscillator
- IMNM 6.71
- MCBS 71.09
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.